Re: TDM-1 results reported @ ASCO annual mtg 2012 now in New England Journal of Medic
yeah , wouldn't it be wonderful, but This FDA needs outside, more objective supervision at this point, Under the new boss , Dr. Hamburg , there's been chaos over there since the beginning, 2009 : FDA workers complaining about having " managers " instead of scientists in charge screwing up, approving defective medical devices. 2010 : thier insensitive denying of avastin to TNBCERS, and taking their anger at Gen's appeal of avastins revoking out on T DM-1. 2011 - FDA spies on its own employees , 2012 : grants only conditional appr to pertuzumab, denying it to Late Stage IV , again disrespecting the pts who are the BACKBONE of ALL RESEARCH ! So, I am pessimistic about This FDA , but the Negative Publicity will turn the tide ...
|